pyrazolanthrone has been researched along with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, R; Han, Y; Huang, S; Li, M; Li, W; Ma, C; Mao, Z; Shi, L; Su, X; Wang, W; Xie, Y; Zhu, Z | 1 |
Tian, QY; Wang, YS; Wei, ZF; Zhang, YX; Zhou, HX; Zhou, JP | 1 |
Li, H; Wang, Y; Wei, Z; Zhang, Y; Zhang, Z; Zhou, H | 1 |
3 other study(ies) available for pyrazolanthrone and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
Article | Year |
---|---|
SP600125, a new JNK inhibitor, protects dopaminergic neurons in the MPTP model of Parkinson's disease.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Anthracenes; Corpus Striatum; Dopamine; Dose-Response Relationship, Drug; Enzyme Activation; Enzyme Inhibitors; JNK Mitogen-Activated Protein Kinases; Male; Mice; Mice, Inbred C57BL; Mitogen-Activated Protein Kinases; MPTP Poisoning; Neurons | 2004 |
[Effect of phosphorylated c-Jun expression on COX-2 expression in the substantia nigra of MPTP mouse model of subacute Parkinson disease].
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Anthracenes; Blotting, Western; Cell Death; Cyclooxygenase 2; Disease Models, Animal; Dopamine; Gene Expression Regulation, Enzymologic; Humans; Immunohistochemistry; Male; MAP Kinase Signaling System; Mice; Mice, Inbred C57BL; Neurons; Parkinson Disease; Phosphoproteins; Phosphorylation; Proto-Oncogene Proteins c-jun; Substantia Nigra | 2007 |
JNK inhibitor protects dopaminergic neurons by reducing COX-2 expression in the MPTP mouse model of subacute Parkinson's disease.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Anthracenes; Cell Death; Cyclooxygenase 2; Disease Models, Animal; Dopamine; Enzyme Inhibitors; JNK Mitogen-Activated Protein Kinases; Male; MAP Kinase Signaling System; Mice; Mice, Inbred C57BL; Movement Disorders; Neurons; Parkinson Disease; Parkinsonian Disorders; Phosphorylation; Proto-Oncogene Proteins c-jun; Random Allocation; Substantia Nigra | 2009 |